Consumer Goods » Leisure & Travel Goods | Valeritas Holdings Inc.

Valeritas Holdings Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
8.60
2,789.00
9,866.00
25,961.00
47,758
Total Accounts Receivable
-
3,635.00
3,635.00
4,233.00
6,294
Inventories
0.90
10,784.00
9,384.00
8,105.00
6,824
Other Current Assets
-
735.00
569.00
634.00
1,200
Total Current Assets
9.50
17,943.00
23,454.00
38,933.00
62,076
Net Property, Plant & Equipment
-
12,091.00
10,219.00
5,469.00
6,097
Other Assets
10.00
1,142.00
843.00
687.00
447
Total Assets
19.50
31,176.00
34,516.00
45,089.00
68,620
ST Debt & Current Portion LT Debt
8.20
69,133.00
-
-
Accounts Payable
15.20
7,419.00
4,591.00
5,644.00
Other Current Liabilities
35.30
7,826.00
7,155.00
7,436.00
Total Current Liabilities
58.80
84,378.00
11,746.00
13,080.00
Long-Term Debt
-
-
58,978.00
36,009.00
Other Liabilities
-
143.00
292.00
58.00
Total Liabilities
58.80
84,521.00
71,016.00
49,147.00
Common Equity (Total)
39.30
53,345.00
36,500.00
4,061.00
Total Shareholders' Equity
39.30
53,345.00
36,500.00
4,058.00
Total Equity
39.30
53,345.00
36,500.00
4,058.00
Liabilities & Shareholders' Equity
19.50
31,176.00
34,516.00
45,089.00
Preferred Stock (Carrying Value)
-
-
-
3.00

About Valeritas Holdings

View Profile
Address
750 Route 202 South
Bridgewater New Jersey 08807
United States
Employees -
Website http://www.valeritas.com
Updated 07/08/2019
Valeritas Holdings, Inc. engages in the development of innovative technologies to improve the health and quality of life of people. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals.